ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
15
views
0
references
Top references
cited by
22
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,435
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Treatment of type II gastric carcinoid tumors with somatostatin analogues.
Author(s):
P Fusaroli
,
P Tomassetti
,
Maria Caletti
,
R Corinaldesi
,
Kristen Gullo
,
M Migliori
Publication date:
2000-08-24
Journal:
The New England journal of medicine
Keywords:
Adult
,
Antineoplastic Agents
,
therapeutic use
,
Carcinoid Tumor
,
drug therapy
,
etiology
,
Female
,
Gastrins
,
blood
,
Humans
,
Male
,
Middle Aged
,
Multiple Endocrine Neoplasia Type 1
,
complications
,
Octreotide
,
Peptides, Cyclic
,
Somatostatin
,
analogs & derivatives
,
Stomach Neoplasms
,
Zollinger-Ellison Syndrome
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
10954763
DOI::
10.1056/NEJM200008243430805
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Antineoplastic Agents
,
therapeutic use
,
Carcinoid Tumor
,
drug therapy
,
etiology
,
Female
,
Gastrins
,
blood
,
Humans
,
Male
,
Middle Aged
,
Multiple Endocrine Neoplasia Type 1
,
complications
,
Octreotide
,
Peptides, Cyclic
,
Somatostatin
,
analogs & derivatives
,
Stomach Neoplasms
,
Zollinger-Ellison Syndrome
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Antineoplastic Agents
,
therapeutic use
,
Carcinoid Tumor
,
drug therapy
,
etiology
,
Female
,
Gastrins
,
blood
,
Humans
,
Male
,
Middle Aged
,
Multiple Endocrine Neoplasia Type 1
,
complications
,
Octreotide
,
Peptides, Cyclic
,
Somatostatin
,
analogs & derivatives
,
Stomach Neoplasms
,
Zollinger-Ellison Syndrome
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,435
Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus.
Authors:
A Vergeylen
,
Joao Sousa
,
Xiao-Nong Zhou
…
Non-Canonical Wnt-Signaling through Ryk Regulates the Generation of Somatostatin- and Parvalbumin-Expressing Cortical Interneurons
Authors:
Melissa McKenzie
,
Lucy Cobbs
,
Patrick D Dummer
…
Carcinoid Heart Disease: Starting From Heart Failure
Authors:
Nicole Bertin
,
Serena Favretto
,
Francesco Pelizzo
…
See all similar
Cited by
22
Gastrointestinal neuroendocrine tumors in 2020
Authors:
Monjur Ahmed
Somatostatin Analogs in Clinical Practice: A Review
Authors:
Mariana Gomes-Porras
,
Jersy Cardenas-Salas
,
Cristina Álvarez-Escolá
Clinical aspects of multiple endocrine neoplasia type 1
Authors:
Abdallah Al-Salameh
,
Guillaume Cadiot
,
Alain Calender
…
See all cited by